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Abstract
Fibril formation by mutational variants of human lysozyme is associated with a fatal form of hereditary non-neuropathic
systemic amyloidosis. Defining the mechanistic details of lysozyme aggregation is of crucial importance for understanding
the origin and progression of this disease and related misfolding conditions. In this study, we show that a biotin moiety can
be introduced site-specifically at Lys33 of human lysozyme. We demonstrate, using biophysical techniques, that the
structure and stability of the native-state of the protein are not detectably altered by this modification, and that the ability
to form amyloid fibrils is unchanged. By taking advantage of biotin-avidin interactions, we show that super-resolution
fluorescence microscopy can generate detailed images of the mature fibrils. This methodology can readily enable the
introduction of additional probes into the protein, thereby providing the means through which to understand, in detail, the
nature of the aggregation process of lysozyme and its variants under a variety of conditions.
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Introduction
Since its discovery in the 1920’s, lysozyme has increasingly
emerged as an important system for studying protein structure and
function [1,2]. Members of the family of c-type lysozymes, which
include the human form, are naturally occurring glycosidases
involved in the degradation of bacterial cell walls. The hen protein
was the first enzyme to have its structure defined at atomic
resolution though X-ray crystallography and its study immediately
shed important light on the mechanism of enzymatic catalysis [3–
5]. The human form of lysozyme is a globular protein containing
130 amino acids and its native structure is typical of the c-type
lysozymes [6]. It has four intramolecular disulphide bonds and two
domains; the a-domain (residues 1–38, and 86–130), which
consists of four a-helices (the A, B, C, and D-helix), and the b-
domain (residues 39–85) containing a significant degree of b-sheet
structure [6].
There have been many investigations of the folding mechanism
of human lysozyme (see references within [7]). These studies
became of particular interest following the discovery of two natural
variants of lysozyme, I56T and D67H, which are linked to
systemic amyloidosis. This fatal disorder is associated with the
enhanced propensity of these naturally occurring mutational
variants to self-assemble into amyloid fibrils [8]. This rare
autosomal-dominant disease involves the accumulation of large
amounts of fibrillar deposits in a wide range of tissues including the
liver, spleen and kidneys [8–10], and is a member of a broader
class of amyloid-related disorders, which include Parkinson’s and
Alzheimer’s disease [11,12]. Since the discovery of the I56T and
D67H variants, four other naturally occurring disease-associated
variants (F57I, F57I/T70N, W64R and T70N/W112R) have
been identified, along with an additional variant (T70N) which is
not disease-associated [13–16].
A range of detailed studies has been carried out to investigate
the effects of these mutations on the in vitro folding and misfolding
properties of human lysozyme. Relative to the wild-type (WT)
lysozyme, the amyloidogenic variants, I56T and D67H, are
characterised by a reduction in both the native state stability and
the global co-operativity of the protein structure [9,17–20]. These
attributes result in the variants, but not the WT protein, being able
to populate transient intermediate species under a variety of
conditions, including those which are physiologically relevant, in
which the b-domain and the C-helix are significantly unfolded,
whilst the remaining parts of the protein maintain native-like
structure [9,18,21]. The transient intermediate species can also be
detected in the non-natural variant, I59T, under similar conditions
and interestingly, they can be detected in both the T70N variant
and WT protein under more highly destabilising conditions
[22,23]. The formation of a transient intermediate has been
identified as a crucial step in lysozyme aggregation through studies
which have made use of camelid antibody fragments to inhibit
amyloid fibril formation [18,24]. Fragments of two distinct
camelid antibodies, cAbHuL-6 and cAbHuL-22, have been found
to bind to the native state of WT lysozyme and the disease-
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associated variants with high affinity and to inhibit fibril formation
by suppressing the formation of the transient intermediates
[24,25]. Along with the numerous in vitro studies, recent in vivo
analysis shows that destabilising mutational variants of human
lysozyme trigger the up-regulation of quality control mechanisms
in Pichia pastoris and in Drosophilia melanogaster model systems
[26,27].
Given the wealth of data detailing the general mechanism of
fibril formation by human lysozyme, it is of great interest to
characterise this process at a molecular level, hence gaining
structural details of the species present on this pathway. Recently,
there have been notable advances in analysing and monitoring the
early stages of amyloid formation using techniques such as single-
molecule fluorescence measurements, fluorescence life-time imag-
ing and multiparameter imaging microscopy [28–30]. The
appearance, composition and structure of early oligomeric species
of the fluorophore-labelled SH3 protein, the Ab1–42 peptide and a-
synuclein, have been the subject of detailed investigations
performed in vitro [30–32]. Studies involving a fusion protein of
a-synuclein and yellow fluorescent protein (YFP) have shown that
a-synuclein-YFP maintains the properties of the unmodified
protein to a remarkable degree. Indeed, using this system we
have been able to define successfully key details of the kinetics of
protein aggregation in vivo [31,33].
To apply these methods to a protein system, it is essential to
introduce a site-specific chemical probe into the protein. In some
instances, fluorophores have been successfully incorporated via the
introduction of single cysteine residues using site-directed muta-
genesis, for example with the SH3 domain or a-synuclein [30,34].
Lysozyme, however, contains eight cysteine residues that are
involved in the formation of four disulphide bonds which help
maintain and stabilise the native structure of the protein [35,36];
the introduction of a chemical probe at a specific cysteine residue
would, therefore, not be straight forward. Other attempts to
modify lysozyme by introducing additional residues at both the C-
terminus and N-terminus of the protein have been found to result
in substantial perturbation to the native state stability of the
protein [37,38]. Recently, however, it has been reported that hen
lysozyme could be labelled via the amine groups of lysine residues
[39–41], however, the effects of the labels on the properties of the
protein were not investigated in detail. Although multiple lysine
residues are often present in proteins, it has been reported that the
accessibility and mobility of individual lysine residues within
proteins, coupled with strategies to control reaction conditions
may result in the labelling of these residues in a selective manner
[42,43].
In this present paper, we describe the labelling of human WT
lysozyme (WTHuL) with an amine reactive reagent, N-(+)-
biotinyl-6-aminocaproic acid N-succinimidyl ester (BioNSE), as a
strategy to incorporate site-specifically chemical reporters into the
protein structure without significantly perturbing its native
properties. Labelling with biotin derivatives has a number of
important advantages; in particular, biotin has a strong specific
affinity to avidin [44]. It can therefore be easily detected via
streptavidin (SA) conjugates which are linked to a variety of
reagents, for example, SA-alkaline phosphatase (AP) for colouri-
metric Western blotting or SA-fluorophores for fluorescence
monitoring techniques [45,46]. Using a number of biophysical
techniques, we confirm in this work that the native structure and
stability of the biotinylated human lysozyme (BioHuL) are
comparable to WTHuL. In addition, we show that BioHuL can
form fibrils in vitro and that we can monitor and visualise clearly,
using super-resolution techniques, the fibrillar aggregates using
streptavidin conjugated fluorophores and reagents.
Materials and Methods
All chemicals were purchased from Sigma-Aldrich (Gillingham,
UK) unless otherwise stated.
Biotin-labelling of lysozyme by N-(+)-biotinyl-6-
aminocaproic acid N-succinimidyl ester (BioNSE)
WT human lysozyme (WTHuL) (7 mM) was dissolved in MES
buffer (100 mM, pH 5) with stirring in a glass vial (5 mL). BioNSE
was freshly dissolved in DMSO (35 mM) immediately before use,
and appropriate aliquots were added to protein solutions to give
1:100 or 1:500 lysozyme-to-BioNSE molar ratios. The samples
were incubated with constant stirring for 20 h at room temper-
ature and dialysed against deionised water (264 h). Mass
spectrometry of the endpoint of the reactions indicated that the
predominant species (,80–90%) was singly-labelled WT lyso-
zyme. Dialysed samples were flash frozen in liquid nitrogen and
lyophilised. The samples were then dissolved in the respective
buffers when required for further analysis.
Purification of biotin-labelled lysozyme
Biotin-labelled lysozyme (BioHuL) samples were dissolved in
Tris buffer (50 mM, pH 8) and purified using a CaptoS ion
exchange column (GE Healthcare, Little Chalfont, UK) on an
AKTA Prime Plus purification system (GE Healthcare). The
protein was eluted using a sodium chloride gradient (0–1 M) and
multiple fractions were collected. The fractions containing protein
were dialysed against deionised water (264 h) and lyophilised. The
protein integrity and purity were confirmed by mass spectrometry
analysis and the final yield of purified protein, as determined by
UV-vis spectroscopy was 5565%. Samples containing the single
biotin-labelled lysozyme were used in further experiments.
Mass spectrometry
Both WTHuL and BioHuL samples were dissolved in deionised
water and de-salted using ZipTips (Millipore, Watford, UK).
Samples were analysed in triplicate on a 4700 Proteomics
Analyzer (Applied Biosystems, Paisley, UK), using matrix-assisted
laser desorption/ionization (MALDI) methodologies.
Circular dichroism (CD) spectroscopy
CD spectroscopy experiments were performed using a Jasco J-
810 spectropolarimeter (JASCO Ltd, Great Dunmow, UK)
equipped with a Peltier temperature controller. WTHuL and
BioHuL samples (20 mM) were dissolved in sodium citrate buffer
(10 mM, pH 5) and analysed using a 0.1 cm or 1 cm path-length
cuvette for far-UV or near-UV spectra, respectively. For
secondary structure analysis, five spectra of each protein sample
and of citrate buffer were recorded between 200 and 250 nm at
20uC (using a scan speed of 50 nm min21 with a 1 nm band width
and a 4 s response time). The spectra of the samples were averaged
and corrected for the background buffer. Thermal denaturation
was monitored at 222 nm or 270 nm as the temperature was
increased monotonically from 5 to 95uC at a rate of 0.5uC min21.
Elipticity values were normalised to the fraction of unfolded
protein (Fu) using Fu = (h–hN)/(hU – hN), where h is the observed
ellipticity, and hN and hU are the ellipticities of the native and the
unfolded states, respectively. hN and hU were extrapolated from
pre- and post-transition baselines at the relevant temperature.
Experimental data were fitted to a sigmoidal expression [47], using
OriginPro 8.0 (OriginLab Corporation, Northhampton, MA,
USA). Mid-point Tm values are defined as the temperatures
where the Fu is 0.5 in each case.
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Nuclear magnetic resonance (NMR) spectroscopy
[15N]-labelled WTHuL was expressed in Pichia pastoris and
purified as previously described [23]. Biotin-labelling of [15N]-
labelled lysozyme was performed as described above for WTHuL.
[15N]-labelled BioHuL or WTHuL (200 mM) was dissolved in
sodium acetate buffer (20 mM, pH 5.0) containing a 90% H2O/
10% 2H2O mixture. The solutions were filtered and sealed in a
Shigemi tube, and data were collected at 37uC using a Bruker
Avance 700 MHz NMR spectrometer equipped with a triple-
resonance cryogenic probe. [15N]-[1H] heteronuclear single
quantum coherence (HSQC) spectra were collected with 1024
and 128 complex points in t1 ([
1H]) and t2 ([
15N]), with sweep
widths of 9470 and 2107 Hz in the [1H] and [15N] dimensions,
respectively. All NMR spectra were processed with NMRpipe [48]
and Sparky (http://www.cgl.ucsf.edu/home/sparky/).
Proteolysis experiments
Proteolysis experiments involving the BioHuL and WTHuL
samples were performed at the Cambridge Centre for Proteomics
(Department of Biochemistry, University of Cambridge, Cam-
bridge, UK). The samples were run on an SDS-PAGE gel and the
bands were excised from the gel and transferred into 96-well PCR
plates. The bands were cut into 1 mm2 pieces, destained, reduced
with DTT and alkylated by treatment with iodoacetamide. The
samples were subjected to enzymatic digestion with trypsin
overnight at 37uC. After digestion, 10 mL aliquots of supernatant
were put into sample vials and loaded onto an autosampler for
automated LC-MS/MS analysis.
All LC-MS/MS experiments were performed using a nanoAcquity
UPLC (Waters Corp., Milford, MA, USA) UPLC system and an LTQ
Orbitrap Velos hybrid ion trap mass spectrometer (Thermo Scientific,
Waltham, MA, USA). Separation of peptides was performed by
reverse-phase chromatography at a flow rate of 300 nL/min, using a
Waters column (BEH C18, 75 mm i.d. 6100 mm, 1.7 mm particle
size).
The LC eluant was sprayed into the mass spectrometer by
means of a New Objective nanospray source (New Objective, Inc.,
Woburn, MA, USA). All m/z values of eluting ions were measured
in an Orbitrap Velos mass analyser, set at a resolution of 30,000.
Data dependent scans (Top 20) were employed to isolate and
generate fragment ions automatically by collision-induced disso-
ciation in the linear ion trap, resulting in the generation of MS/
MS spectra. Ions with charge states of +2 and above were selected
for fragmentation and the data were processed using Protein
Discoverer (version 1.2., Fisher Scientific UK, Loughborough,
UK). All MS/MS data were submitted to the Mascot search
algorithm (Matrix Science, London, UK) and searched against a
custom human protein database, using a fixed modification of
carbamidomethyl (cysteines) and variable modifications of oxida-
tion (methionines) and biotin (lysines).
Enzyme activity assay
50 mL aliquots of BioHuL or WTHuL (6.8 mM) were dissolved
in potassium phosphate buffer (100 mM, pH 7) and placed in
individual wells of a 96-well flat bottom microplate (Fisher
Scientific UK). Micrococcus lysodeikticus cells (9 mg) were suspended
in 30 mL of the potassium phosphate buffer shortly before the
assay, and 200 mL of the cell suspension was added to each well
[49]. Cell lysis was monitored at an absorbance of 595 nm after
shaking and readings were recorded every minute over a 7 min
interval on a FLUOstar Optima plate reader (BMG LABTECH,
Aylesbury, UK). The results were averaged, plotted as a function
of time, and then fitted linearly to calculate the slopes using
OriginPro 8.0.
Fibril formation of lysozyme samples monitored by light
scattering or thioflavin-T binding
Aggregation studies were performed with BioHuL or WTHuL
(6.8 mM, 3 M urea, 0.1 M sodium citrate buffer, pH 5.0, and
62.5 mM thioflavin-T (Thio-T)) incubated with stirring at 60uC in
a Cary Eclipse spectrofluorimeter (Agilent Ltd., Oxford, UK).
Thio-T fluorescence was measured with an excitation wavelength
of 450 nm (slit width 5 nm) and monitored at an emission
wavelength of 480 nm (slit width 5 nm). Fibrils for further
experiments were prepared under similar conditions but in the
absence of Thio-T; aggregation was monitored by light scattering
at 500 nm with slit widths of 5 nm. All experiments were
performed in triplicate.
Seeded aggregation reactions
BioHuL or WTHuL fibrils were prepared as described above in
the absence of Thio-T. The endpoint fibrils were sonicated using a
Bandelin Sonoplus probe sonicator (Bandelin, Berlin, Germany),
which was set at the minimum power level, pulsing 10% of the
time over a five minute period. Aliquots of the sonicated fibrils
(10% v/v) were added at the beginning of an aggregation time
course reaction (6.8 mM, 3 M urea, 0.1 M sodium citrate buffer,
pH 5.0, and 62.5 mM Thio-T) and the effects were monitored by
changes in Thio-T fluorescence. Seeding experiments were
monitored for WTHuL with the addition of BioHuL fibril seeds
or WT fibril seeds and for BioHuL in the presence of WTHuL
fibril seeds or BioHuL fibril seeds.
Transmission electron microscopy (TEM)
Fibril samples (5 mL) collected at the endpoint of the aggrega-
tion reactions were applied to Formvar-coated nickel grids. The
samples were stained with 2% (w/v) uranyl acetate, and imaged
using a FEI Tecnai G2 transmission electron microscope (Multi-
Imaging Unit in the Department of Physiology, Development and
Neuroscience, University of Cambridge, UK) Images were
analysed using the SIS Megaview II Image Capture system
(Olympus).
Dot blot assays
Samples taken from the endpoint of the aggregation reactions
were centrifuged (16,000 x g, 10 min) and the supernatants
removed. The pellets were washed three times with dH2O
followed by centrifugation. The rinsed fibrils were resuspended
in dH2O, (20 mL) and immobilised onto a nitrocellulose
membrane (Whatman International Ltd., Maidstone, UK). The
membrane was blocked with BSA (1% in phosphate buffered
saline (PBS), 2 h), followed by incubation with streptavidin
conjugated to alkaline phosphatase (AP) (Life Technologies,
Paisley, UK) for 1 h. The membrane was washed three times
with dH2O and developed using a 5-bromo-4-chloro-3-indolyl
phosphate/nitroblue tetrazolium (BCIP/NBT) solution.
Measurement of fibril stabilities
To measure the stability of fibrillar BioHuL and WTHuL,
aliquots of fibrils were diluted into 0.1 M citrate buffer (pH 5.0)
containing increasing concentrations of guanidinium hydrochloride
(GdnHCl). After 48 hrs at 25uC, the samples were centrifuged
(16,0006 g, 15 min) and the concentration of lysozyme in the
supernatant was measured by recording the absorbance at 280 nm.
The depolymerisation curves were obtained by plotting the fraction
of lysozyme released from the fibrils at different concentrations of
GdnHCl. The final concentration of GdnHCl was determined by
refractometry using [GdnHCl] = 57.147(Dn)+38.68(Dn)22
Structural Analysis of Biotinylated Human Lysozyme
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e50192
91.60(Dn)3, where Dn is the difference between the refractive indices
of GdnHCl solution and the 0.1 M citrate buffer [50].
dSTORM imaging experiments
Samples of BioHuL fibrils (10 mL) were placed on cover glass
slips (18 mm 618 mm, 17065 mm thickness; Carl Zeiss Ltd.,
Welwyn Garden City, UK) and incubated with streptavidin-Alexa
647 (0.2 mg/mL) (Life Technologies Ltd.) for 1 h, followed by
washing three times with PBS buffer. The switching buffer,
composed of PBS (pH 7.4) containing an oxygen scavenger
(0.5 mg mL21 glucose oxidase, 40 mg mL21 catalase (Roche
Applied Science, Welwyn Garden City, UK), 10% w/v glucose)
and 50 mM b-mercaptoethylamine (MEA), was prepared as
previously described and loaded into a single cavity (15 mm
diameter) glass microscope slide (Fisher Scientific UK) [51]. The
cover glass with the fibrils was gently placed on the glass slide with
the fibrils in contact with the switching buffer; bubbles were
removed and the sample sealed with nitrocellulose solution to
prevent evaporation. Super-resolution images were captured using
a modified Nikon TE200 inverted total internal reflection (TIRF)
microscope (Nikon Ltd. UK, Kingston upon Thames, UK). Fibre
coupled diode lasers operating at 642 nm (150 mW) (Toptica
Photonic AG, Graefelfing, Germany) and 405 nm (120 mW)
(Mitsubishi Electronics Corp., Tokyo, Japan), were used as
excitation and reactivation lasers, respectively. The laser beams
were expanded and focused into the back focal plane of a 100X
oil-immersion objective (Nikon UK Ltd.) BioHuL fibrils were
imaged in TIRF mode for best contrast. A filter set containing a
quad-edge laser flat dichroic beamsplitter (Semrock, Rochester
NY, USA) and two emission filters (Semrock) were applied to
eliminate straight fluorescent and excitation light. Typically,
10,000 image frames with an exposure time of 50 ms and field
of view of 64664 pixels were captured using a low-noise, highly
sensitive electron-multiplying CCD camera (Andor iXon 897,
Belfast, UK). The exposure time was matched with the ON state
time of the fluorescent Alexa Fluor 647 dye [52]. During data
acquisition the intensity of the excitation laser on the sample was
1.5 kW/cm2 and the reactivation laser was only turned on when
the number of active fluorophores in the field of view dropped,
and no spatial drift of the sample was observed during the
measurements. From the captured and stored image stack, a
reconstructed dSTORM image was generated in each case using
in-house developed software based on Matlab (The MatWork Inc.,
Natick, USA). The software sequentially segments and localises
isolated fluorescent molecules on each image frame and recon-
structs the final super-resolved image. The localisation precision
was determined on the basis of the number of photons captured
per molecule [53].
dSTORM imaging in SH-SY5Y cells
Human neuroblastoma cells (SH-SY5Y) were obtained from the
European Collection of Cell Cultures (Sigma-Aldrich, Dorset, UK)
and grown in 1:1 minimal essential medium (MEM) and nutrient
mixture F-12 Ham (Sigma) with sodium bicarbonate, including
15% heat inactivated foetal bovine serum, 1% MEM non-essential
amino acids, 2 mM N-glutamine, 1% penicillin-streptomycin
(10,000 U ml K1) and 0.1% fungizone (amphotericin B, 250 mg
mL21 K1) (Life Technologies Ltd.).
Cells were harvested using trypsin (0.5 g L21 of trypsin) with
EDTA (0.2 g L21 of EDTA 4Na) in Hanks9 Balanced Salt
Solution (Life Technologies Ltd.), rinsed with growth medium and
divided into 16106 cells in each 1.7 cm2 polystyrene chamber
slide well (Lab-TekTM II, Fisher Scientific UK, Ltd.). Cells were
subsequently transfected using an Amaxa nucleofector (Lonza,
Cologne, Germany) with 35 ng of BioHuL fibrils in nucleofection
buffer (Lonza).
Twenty four hours after electroporation the cells were washed
three times with PBS, fixed for 10 min with formaldehyde (4% in
PBS) before washing the cells three times with PBS. Tween (0.5%
in PBS) was applied to the cells for 10 min for permeabilisation,
followed by washing three times with PBS. After permeabilisation,
the cells were incubated with Streptavidin-Alexa 647 (2 ng mL21,
Life Technologies Ltd.) for 30 min and washed three times with
PBS. Switching buffer, as detailed above for in vitro super-
resolution imaging, was added prior to imaging the cells. The
samples were imaged by differential interference contrast (DIC)
microscopy followed by single-molecule super-resolution imaging
as detailed above.
Results
Site-specific biotin labelling of WT human lysozyme
WT human lysozyme was incubated with different molar ratios
of BioNSE and the reactions were analysed using MALDI mass
spectrometry (Figure 1A). We observed that by incubating WT
lysozyme overnight at room temperature with a 100-fold molar
excess of BioNSE, the predominant resulting species is WT
lysozyme modified with a single biotin moiety (BioHuL),
displaying a peak at 15,03361.5 Da. When the reaction was
performed with a 500-fold excess of BioNSE, a less intense second
peak at 15,37261.5 Da becomes evident, corresponding to the
incorporation of two biotin moieties within WT lysozyme. Using
ion exchange chromatography, the singly-labelled BioHuL pro-
tein, formed following incubation under these conditions, was
purified from both the unmodified protein and the doubly-labelled
lysozyme.
To identify the site of the modification, the singly-labelled
BioHuL sample was subjected to trypsin proteolysis and analysed
by mass spectrometry. The analysis reveals that the singly-labelled
BioHuL displays a substantial change in the tryptic digestion
pattern, and that modification of Lys33 results in the loss of a
trypsin cleavage site. This results in the appearance of a longer
peptide fragment (residues 22–41) in BioHuL than the fragment
observed in WTHuL (residues 22–32) (Figure 1B) [54–56]. Despite
WT human lysozyme having five lysine residues (Lys1, Lys13,
Lys33, Lys69 and Lys97) which, according to the X-ray structure,
all have side-chain amine groups that are highly solvent accessible
and thus, in principle, able to react with an N-hydroxy-
succinimide (NHS) ester group to which a chemical probe is
attached, we have demonstrated that site-specific labelling of just
one of these residues, Lys33, can be achieved. Previous reports of
labelling lysine residues by a variety of techniques in hen lysozyme
reveal that Lys33 again appears to be the most reactive lysine
residue [41,57–59].
Effect of biotinylation on protein structure and native-
state stability
Although it is possible to label WT human lysozyme site-
specifically, there are no data available as to whether this
modification affects the structural properties of the protein. We
therefore used a number of biophysical techniques to compare the
BioHuL protein, generated as described above, with that of the
unlabelled WTHuL protein. Far-UV CD spectroscopy, which
monitors the secondary structure change within the protein, shows
that the secondary structure content of BioHuL is closely similar to
that of the WTHuL (Figure 1C). Near-UV CD, which reports on
tertiary structural changes within the protein, reveals that BioHuL
and WTHuL have essentially identical thermal stability with Tm
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values of 76.060.5uC and 75.960.5uC, respectively (Figure 1D).
Tm values of BioHuL and WTHuL obtained by far-UV CD also
show comparable thermal stability data (data not shown). Given
that BioHuL is structurally similar to WTHuL, we compared the
enzyme activity of the two proteins by measuring their ability to
lyse Micrococcus lysodeikitcus cells [49]. The BioHuL protein retains
about 60% enzymatic activity as compared to WTHuL.
In order to understand the effects of the biotin-labelling on the
protein at the level of individual residues, we compared the
15N-1H heteronuclear single quantum coherence (15N-1H HSQC)
NMR spectra of BioHuL and WTHuL (Figure 2). In general, the
parameters defining the backbone amide resonances of BioHuL
are closely similar to those of WTHuL (Figure 2A). The chemical
shifts (Dd values) in particular, were compared closely (Figure 2B),
and are shown mapped onto the structure of human lysozyme
(Figure 2C). This comparison shows that the residues most affected
by the modification are Trp34 (W34) and Glu35 (E35); the latter
residue acts as an essential catalytic acid/base in lysozyme enzyme
activity [5]. A combination of steric hindrance due to the biotin
moiety preventing substrate binding, along with the perturbation
to Glu35 due to the modification at residue 33, may provide some
explanation for the slight decrease in overall enzymatic activity of
BioHuL as compared to WTHuL. Although some minor
perturbations were observed in residues that are spatially close
to Lys33 (K33) (Figure 2C), the majority of Dd values remained
below 0.05 ppm indicating that there are no detectable perturba-
tions of the signals of residues adjacent to other lysine residues.
The chemical shift data therefore further supports the conclusion
that the site of modification is indeed Lys33.
Biotinylated lysozyme forms fibrils similar to WT
lysozyme
Our analysis has revealed that BioHuL possesses similar native-
state properties to that of WTHuL. We next investigated the
misfolding and formation of fibrillar species by BioHuL. Amyloid
fibrils have been shown to be formed in vitro from WT lysozyme
under a number of different solution conditions that involve
destabilisation of the native-state, notably by the use of elevated
temperatures at low pH or in the presence of chemical denaturants
[24,60–62]. Here, we incubated both BioHuL and WTHuL
proteins at 60uC in 0.1 M citrate buffer (pH 5.0) in the presence of
3 M urea and monitored, in each case, enhancement of thioflavin-
T (Thio-T) fluorescence to follow the formation of ordered
amyloid aggregates. Both proteins were observed to form fibrils
after a lag phase of approximately 4 hours and displayed typical
sigmoidal curves (Figure 3A). The endpoint samples were analysed
Figure 1. Effects of biotinylation on lysozyme. (A) MALDI mass spectrometry of lysozyme incubated in the absence (upper) and the presence
(lower) of 100-fold molar concentration of BioNSE. (B) Primary sequence of human lysozyme showing the sites where trypsin digestion has occurred
in BioHuL (open grey arrows) and WTHuL (filled black arrows). (C) Secondary structure of BioHuL (dashed grey line) and WTHuL (solid black line) by
far-UV CD. (D) Thermal denaturation curves of BioHuL (open grey circles) and WTHuL (filled black squares) monitored by near-UV CD. Mid-point Tm
values are defined as the temperatures at which 50% of the population of protein molecules is unfolded.
doi:10.1371/journal.pone.0050192.g001
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by transmission electron microscopy (TEM), and the resulting
images confirmed that the size and morphology of the fibrils
formed by BioHuL are effectively identical to those formed by
WTHuL. In addition, these fibrils clearly resemble those formed in
previous studies where WTHuL fibrils were generated at pH of 7.5
(60uC) [62]; in each case, the fibrils appear bundled and
intertwined together with lengths around 1-2 mm and about
100 nm in thickness (Figure 3B).
Although the endpoint fibrils appear very similar in the TEM
images, we also investigated whether the fibrillar seeds formed
from BioHuL and WTHuL could cross-seed the aggregation
reactions of WTHuL and BioHuL respectively. Indeed, the
addition of 10% (v/v) preformed fibril seeds is highly efficient at
promoting aggregation in the cross-seeding reactions which
suggests that the fibrils formed in both instances have similar
morphologies (Figure 3D). In order to assess the conformational
Figure 2. Mapping the location of modification by NMR spectroscopy. (A) Overlaid HSQC NMR spectra at 700 MHz of BioHuL (red) and
WTHuL (blue); the spectra were collected at pH 5.0 and 37uC (B) Chemical shift changes defined as [0.04(d15NWT2d
15NBiotin)
2+(d1HWT2d1HBiotin)2]1/2 in
BioHuL with respect to WTHuL [68]. (C) Structural identification of the BioHuL protein colour-coded by Dd value of each residue observed in (B) with
the modified Lys33 labelled in red. Dark blue represents the lowest Dd value, whilst red represents the highest. Residues whose chemical shifts are
most perturbed by the modification are identified. The black line in the centre of the two images represents the axis of rotation by 180u.
doi:10.1371/journal.pone.0050192.g002
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stability of the BioHuL and WTHuL fibrils, we measured the
resistance of the fibrils to depolymerisation by incubating fibril
aliquots in solutions containing guanidinium hydrochloride
(GdnHCl) and measuring the concentration of soluble monomer
released into the supernatant. The plots of the fraction of soluble
protein present at increasing GdnHCl concentrations are shown in
Figure 3E. Both the BioHuL and WTHuL fibrils have similar
midpoints of depolymerisation, 5.560.5 M and 5.260.3 M
respectively, therefore demonstrating similar conformational
stability.
We next set out to determine if the biotin moiety remains
solvent accessible in the BioHuL fibrils formed in 3 M urea at
pH 5.0, by using a dot blot assay; by taking advantage of the very
high affinity of biotin for the protein, streptavidin [44], we used
streptavidin conjugates to probe for the presence of biotin in the
BioHuL fibrils. In this assay, the fibrils were washed and
immobilised onto nitrocellulose and the membrane was then
probed with a streptavidin-alkaline phosphatase conjugate; alka-
line phosphatase activity was then measured, resulting in a
colourimetric reaction. To ensure that the centrifugation and
washing of the fibrils did not alter the morphology, the structures
of the samples were confirmed by TEM imaging and no changes
were observed. Both the monomer and fibrils of BioHuL give a
positive signal for the presence of biotin (Figure 3C), showing that
the biotin-moiety is solvent exposed in the fibrils and therefore
can, in principle, act as a useful tag for characterising the species
formed during aggregation.
Finally, we labelled the BioHuL fibril samples with streptavidin-
Alexa647 and imaged them directly using direct stochastic optical
reconstruction microscopy (dSTORM); this super-resolution im-
aging technique can provide information on spatial scales as low as
20 nm, much smaller than the wavelength of the probing light
Figure 3. Fibril formation of BioHuL. (A) In situ Thio-T binding fluorescence kinetics of BioHuL (grey) and WTHuL (black) incubated in the
presence of 3 M urea in 0.1 M citrate buffer (pH 5.0) with constant stirring at 60uC. (B) TEM images of the endpoint samples of the aggregation
reactions performed in the absence Thio-T. Images on the left and right show the fibrils formed by WTHuL and BioHuL, respectively; the scale bars
represent 500 nm. (C) Dot blot assay of fibrils formed by WTHuL (upper row) and BioHuL (bottom row). Samples include the monomeric protein, the
supernatant solutions after washing the fibril pellets (1st, 2nd, and 3rd) and the final washed fibrils. The appearance of colour indicates a positive
interaction between biotin and streptavidin-AP. (D) In situ Thio-T binding fluorescence kinetics of WTHuL in the absence (solid line) and presence of
10% BioHuL fibril seeds (dashed line) incubated under similar conditions as (A). (Inset) TEM images of the WTHuL fibrils formed in the presence of
BioHuL fibril seeds; the scale bar represents 500 nm. (E) Conformational stability of BioHuL (grey open circles) and WTHuL (black squares) fibrils. The
stability of the fibrils was measured by depolymerisation experiments performed using GdnHCl at pH 5.0. Continuous lines represent the best fits to
sigmoidal functions.
doi:10.1371/journal.pone.0050192.g003
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[52]. In a related study we have shown that dSTORM can be used
to identify structural differences between aggregated states of
fluorescently-labelled Ab1–42 peptide formed both in vitro and in
cells [63]. The dSTORM analysis of the BioHuL aggregates
clearly reveals fluorescent fibrils with greatly improved resolution
compared to that achievable with conventional fluorescence
techniques (Figure 4). Figure 4D shows a fibril bundle with a
diameter of 133620 nm, which is comparable to the diameter
observed in the TEM images of similar bundles (approximately
100–200 nm) (Figure 3B).
dSTORM not only offers high resolution structures of single
fluorophore labelled samples, but it offers the compelling
advantage of using multiple fluorophores which allows the imaging
of various proteins simultaneously and selectively [64]. Another
great advantage provided by dSTORM is that it is possible to
apply this technique in situ thereby allowing direct imaging of
species within the cellular environment. To demonstrate this
capacity, we introduced BioHuL fibrils, prepared by the in vitro
methods, into SH-SY5Y mammalian cells using an electroporation
technique previously reported [33]. After washing the cells and
permeabilising them with 0.5% v/v Triton-X 100, the streptavi-
din-Alexa647 conjugate was added. Differential interference
contrast (DIC) microscopy imaging confirms that the BioHuL
fibrils are present inside the SH-SY5Y cells (Figure 4F, left panel)
and a traditional fluorescence image is shown (Figure 4F, middle
panel) along with a subsequent dSTORM image of the BioHuL
fibrils inside the SH-SY5Y cells (Figure 4F, right panel). As
amyloidogenic lysozyme fibrils are found in patients as extracel-
lular deposits [8], it is interesting that the fibrils introduced to the
intracellular environment appear somewhat the same in structure
to those observed in the in vitro images in Figure 4A–C. Although
much further work is needed to understand the significant of these
preliminary data, the results demonstrate that super-resolution
imaging of biotin-labelled lysozyme has real potential for
characterising the process of fibril formation, and therefore for
investigating the effect of potential modulators of fibril formation
both in vitro and in a cellular environment.
Discussion
In this study, we have successfully introduced a site-specific
biotin label into WT human lysozyme and have shown that this
modification has no significant effects on native-state structure and
stability or on the process of in vitro fibril formation by the
biotinylated lysozyme. It has been demonstrated in previous
studies that the regions of human lysozyme containing the b-
Figure 4. dSTORM images of BioHuL fibrils. (A)–(C) Super-resolution dSTORM images of different BioHuL fibrils (formed in vitro). (D) An overlay
of a straight BioHuL fibril with its fluorescence sum image. (E) The cross-sections of the individual fluorescence sum and the super-resolved dSTORM
image of the BioHuL fibril displayed in panel (D). The full-width half-maximum (FWHM) of the fluorescence intensity distribution of the unresolved
sum image depicts a fibril diameter of 783 nm whereas the super-resolved image depicts a fibril diameter of 133620 nm; the latter showing 6 times
better resolution. (F) (left panel) DIC image of BioHuL present within SH-SY5Y mammalian cells after probing with streptavidin-Alexa647. (middle
panel) Fluorescence sum image of a region within the SH-SY5Y cells (right panels) Super-resolution dSTORM images of BioHuL fibrils in the same
region of the SH-SY5Y mammalian cells as the fluorescence sum image. All scale bars all represent 1 mm.
doi:10.1371/journal.pone.0050192.g004
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domain and the C-helix in the native state are unfolded in the
transiently partially unfolded intermediate which is crucial for
fibril formation [24,65]. The location of Lys33 is within the B-
helix, on a solvent exposed face of the a-domain in the native state
of human lysozyme, and this region is not directly involved in the
formation of the transient intermediate; therefore, it is consistent
that modification to this residue does not result in significant
changes to the process of in vitro fibril formation. The position of
the biotin modification has the great advantage that we are able to
probe the BioHuL fibrils formed at pH 5.0 via a streptavidin-AP
conjugate; our results show that the biotin moiety resides on an
exposed surface, and thus in an accessible region of the fibrils. We
exploit this property to obtain fluorescence microscopy images of
the mature fibrils, both in solution and following introduction into
SH-SY5Y mammalian cells, at very high resolution using the
dSTORM super-resolution imaging technique.
The availability of the biotin moiety located on Lys33 for
detection with streptavidin conjugates provides strong evidence
that the size of the fibrillar core of these fibrils more closely
resembles that of WTHuL fibrils formed at pH 7.5, 60uC than to
those formed at pH 1.5, 45uC [60,62]. For the latter, on the basis
of limited proteolysis experiments, the fibrillar core has been
suggested to consist of residues 32–108 [60] and FTIR analysis
confirms that 75% of the sequence exists as b-sheet structure. In
contrast, fibrils formed at the higher pH were found to have a
different morphology, and although the core region has not been
defined in detail by limited proteolysis experiments, it has been
found to consist of a distinctly smaller b-core region, with 45% of
the sequence in b-sheet structure [62]. The location of a chemical
probe at Lys33 should be very useful for monitoring conforma-
tional changes throughout the process of fibril formation at
physiologically relevant pH values. In addition, ready availability
of a variety of succinimide ester-conjugated probes will enable us
to use the site-specific modification technique described in this
study to introduce a wide range of chemical species into human
lysozyme, opening up the prospects for a wide range of studies
involving, for example, spin-labelling NMR and single-molecule
fluorescence experiments [32,52,66,67]. These studies should
allow us to gain insight into the molecular details of species
present along the fibril forming pathway of human lysozyme, and
hence, to describe in molecular detail, the mechanism of this
extremely important disease-associated process.
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